Koch, T., Dahlke, C., Fathi, A., Kupke, A., Krähling, V., Okba, N. M. A., . . . Addo, M. M. (2020). Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: An open-label, phase 1 trial. Lancet Infect Dis.
Citación estilo ChicagoKoch, Till, et al. "Safety and Immunogenicity of a Modified Vaccinia Virus Ankara Vector Vaccine Candidate for Middle East Respiratory Syndrome: An Open-label, Phase 1 Trial." Lancet Infect Dis 2020.
Cita MLAKoch, Till, et al. "Safety and Immunogenicity of a Modified Vaccinia Virus Ankara Vector Vaccine Candidate for Middle East Respiratory Syndrome: An Open-label, Phase 1 Trial." Lancet Infect Dis 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.